Preparation and Characterization of Albendazole Nanosuspensions for Oral Delivery

REFERENCES

• Cook , G. C. 1990 . Use of benzimidazole chemotherapy in human helminthiases: indications and efficacy . Parasitol. Today , 6 : 133 – 136 .
   Google Scholar
• Wen , H. , New , R. R. C. and Craig , P. S. 1993 . Diagnosis and treatment of human hydatidosis . Br. J. Clin. Pharm. , 35 : 565 – 574 .
   Google Scholar
• WHO Informal Working Group on Echinococcosis. 1996 . Guidelines for treatment of cystic alveolar echinococcosis in humans . Bull. WHO , 74 : 231 – 242 .
   Google Scholar
• Misra , P. K. , Kumar , A. , Agarwal , U. and Jagota , S. C. 1995 . A comparative clinical trial of albendazole vs metronidazole in giardiasis . Indian Pediatr. , 32 : 291 – 294 .
   Google Scholar
• Lecuit , N. , Oksenhendler , E. and Sarfati , C. 1994 . The use of albendazole for disseminated microsporidian infection in patients with AIDS . Clin. Infect. Dis. , 19 : 332 – 333 .
   Google Scholar
• Lopez-Garcia , M. L. , Torrado-Duran , S. , Torrado-Duran , J. , Martinez , A. R. and Bolas , F. 1997 . Albendazole versus ricobendazole against enteral and parenteral stages of Trichinella spiralis in mice . Int. J. Parasitol. , 27 : 781 – 785 .
   Google Scholar
• Keramidas , D. , Mavridis , G. , Soutis , M. and Passalidis , A. 2004 . Medical treatment of pulmonary hydatidosis: complications and surgical management . Pediatr. Surg. Int. , 19 : 774 – 776 .
   Google Scholar
• Del-Brutto , O. H. , Sotelo , I. and Raman , G. C. 1993 . Therapy for neurocysticercosis: a reappraisal . Clin. Infect. Dis. , 17 : 730 – 33 .
   Google Scholar
• Gil-Grande , L. A. , Rodriguez-Caabeiro , F. , Prieto , J. G. , Sánchez-Ruano , J. J. and Brasa , C. 1993 . Randomised controlled trial of efficacy of Albendazole in intra-abdominal hydatid disease . Lancet , 342 : 1269 – 1272 .
   Google Scholar
• Van–Nieuwkerk , K. M. J. , Veenstra , J. , Wassenaar , R. P. , Blaauwgeers , H. L. , Geraedts , A. A. and Kroes , H. 1993 . Pancreatitis causes by rupture of liver hydatid cyst . Eur. J. Gastroenterol. Hepatol. , 5 : 563 – 65 .
   Google Scholar
• Yasawy , M. I. , ALKarawi , M. A. and Are , M. 1993 . Combination of praziquantel and albendazole in the treatment of hydatid disease . Trop. Med. Parasitol. , 44 : 192 – 195 .
   Google Scholar
• Amidon , G. L. , Lennernas , H. , Shah , V. P. and Crison , J. R. 1995 . A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability . Pharm. Res. , 12 : 413 – 420 .
   Google Scholar
• Jung , H. , Medina , L. , Garcia , L. , Fuentes , I. and Esparza , R. M. 1998 . Absorption studies of albendazole and some physicochemical properties of the drug and its metabolite, albendazole sulphoxide . J. Pharm. Pharmacol. , 50 : 43 – 48 .
   Google Scholar
• Torrado , S. S. , Lopez , M. L. , Torrado , G. , Bolas , G. , Torrado , S. and Cadorniga , R. 1997 . A novel formulation of albendazole solution: oral bioavailability and efficacy evaluation . Int. J. Pharm. , 156 : 181 – 87 .
   Google Scholar
• Torrado , S. , Torrado , S. , Torrado , J. J. and Cadorniga , R. 1996 . Preparation, dissolution and characterization of albendazole solid dispersions . Int. J. Pharm. , 140 : 247 – 50 .
   Google Scholar
• Jacobs , C. , Kayser , O. and Muller , R. H. 2000 . Nanosuspensions as a new approach for the formulation for the poorly soluble drug tarazepide . Int. J. Pharm. , 196 : 161 – 164 .
   Google Scholar
• Kayser , O. , Olbrich , C. , Yardley , V. , Kiderlen , A. F. and Croft , S. L. 2003 . Formulation of amphotericin B as nanosuspension for oral administration . Int. J. Pharm. , 254 : 73 – 75 .
   Google Scholar
• Ravichandran , R. 2009 . Nanoparticles in drug delivery: potential green nanobiomedicine applications . Int. J. Green Nanotechnol. Biomed. , 1 : B108 – B130 .
   Google Scholar
• Ravichandran , R. 2009 . Nanotechnology-based drug delivery systems . NanoBiotechnology , 5 ( 1 ) : 17 – 33 .
   Google Scholar
• Chen , X. , Young , T. J. , Sarkari , M. , Williams , R. O. and Johnston , K. P. 2002 . Preparation of cyclosporine: a nanoparticles by evaporative precipitation into aqueous solution . Int. J. Pharm. , 242 : 3 – 14 .
   Google Scholar
• Muller , R. H. , Jacobs , C. and Kayser , O. 2001 . Nanosuspensions as particulate drug formulations in therapy: rationale for development and what we can expect for the future . Ad. Drug Del. Rev. , 47 : 3 – 19 .
   Google Scholar
• Weder , H. G. and van Hoogevest , P. Nanosuspensions for intravenous administration . US 5726164 . 1998 .
   Google Scholar
• Muller , R. H. and Jacobs , C. 2002 . Buparvaquone mucoadhesive nanosuspensions: Preparation, optimisation and long-term stability . Int. J. Pharm. , 237 : 151 – 161 .
   Google Scholar
• Rabinow , B. E. 2004 . Nanosuspensions in drug delivery . Nat. Rev. Drug. Discov. , 3 : 785 – 96 .
   Google Scholar
• Keck , C. M. and Muller , R. H. 2006 . Drug nanocrystals of poorly soluble drugs produced by high pressure homogenization . Eur. J. Pharm. Biopharm. , 62 : 3 – 16 .
   Google Scholar
• Liversidge , G. G. and Cundy , K. C. 1995 . Particle size reduction for improvement of oral bioavailability of hydrophobic drugs: I. Absolute oral bioavailability of nanocrystalline danazol in beagle dogs . Int. J. Pharm. , 125 : 91 – 97 .
   Google Scholar
• Jinno , J. , Naoki , K. , Miyake , M. , Yamada , K. , Mukia , T. , Odomi , M. , Togu-chi , H. , Liversidge , G. G. , Higaki , K. and Kimura , T. 2006 . Effect of particle size reduction on dissolution and oral absorption of a poorly water-soluble drug, cilostazol, in beagle dogs . J. Control. Release , 111 : 56 – 64 .
   Google Scholar
• Liversidge , G. G. and Conzentino , P. 1995 . Drug particle size reduction for decreasing gastric irritancy and enhancing absorption of naproxen in rats . Int. J. Pharm. , 125 : 309 – 313 .
   Google Scholar
• Rao , Y. M. , Kumar , M. P. and Apte , S. 2008 . Formulation of nanosuspensions of albendazole for oral administration . Curr. Nanosci. , 4 : 53 – 58 .
   Google Scholar
• Pavan Kumar , M. , Madhusudan Rao , Y. and Apte , S. 2007 . Improved bioavailability of albendazole following oral administration of nanosuspension in rats . Curr. Nanosci. , 3 : 191 – 194 .
   Google Scholar
• Auweter , H. , Bohn , H. and Luddecke , E. 2000 . Stable aqueous dispersions and stable water-dispersible dry powders of xanthophylls and production and use of the same PCT Application no: PCT/EP2000/003467, Europe
   Google Scholar
• Loftsson , T. , Brewster , M. E. and Masson , M. 2004 . Role of cyclodextrins in improving oral drug delivery . Am. J. Drug Deliv. , 2 : 1 – 15 .
   Google Scholar
• Loftsson , T. and Duchene , D. 2007 . Cyclodextrins and their pharmaceutical applications . Int. J Pharm. , 329 : 1 – 11 .
   Google Scholar
• Muller , R. H. , Jacobs , C. and Kayser , O. 2003 . “ DissoCubes—a novel formulation for poorly soluble and poorly bioavailable drugs ” . In Modified-Release Drug Delivery Systems , Edited by: Rathbone , M. J. , Hadgraft , J. and Roberts , M. S. 135 – 149 . New York : Marcel Dekker .
   Google Scholar
• Langguth , P. , Hanafy , A. , Frenzel , D. , Grenier , P. , Nhamias , A. , Ohlig , T. , Vergnault , G. and Spahn-Langguth , H. 2005 . Nanosuspension formulations for low-soluble drugs: pharmacokinetic evaluation using spironolactone as model compound . Drug Dev. Ind. Pharm. , 31 : 319 – 329 .
   Google Scholar
• Krause , K. P. and Muller , R. H. 2001 . Production and characterization of highly concentrated nanosuspensions by high pressure homogenisation . Int. J. Pharm. , 214 : 21 – 24 .
   Google Scholar
• Muller , R. H. and Bohm , B. H. L. 1998 . “ Nanosuspensions ” . In Emulsions and Nanosuspensions for the Formulation of Poorly Soluble Drugs , Edited by: Muller , R. H. , Benita , S. and Bohm , B. 149 – 173 . Stuttgart : Medpharm Scientific .
   Google Scholar
• Wong , J. , Brugger , A. , Khare , A. , Chaubal , M. , Papadopoulos , P. , Rabinow , B. , Kipp , J. and Ning , J. 2008 . Suspensions for intravenous (IV) injection: a review of development, preclinical and clinical aspects . Adv. Drug Deliv. Rev. , 60 : 939 – 954 .
   Google Scholar
• Lindfors , L. , Skantze , P. , Skantze , U. , Rasmusson , M. , Zackrisson , A. and Olsson , U. 2006 . Amorphous drug nanosuspensions. 1. Inhibition of Ostwald ripening . Langmuir , 22 : 906 – 910 .
   Google Scholar
• Lindfors , L. , Skantze , P. , Skantze , U. , Westergren , J. and Olsson , U. 2007 . Amorphous drug nanosuspensions. 3. Particle dissolution and crystal growth . Langmuir , 23 : 9866 – 9874 .
   Google Scholar
• Higuchi , W. I. and Misra , J. 1962 . Physical degradation of emulsions via the molecular diffusion route and the possible prevention thereof . J. Pharm. Sci. , 51 : 459 – 466 .
   Google Scholar
• Chickering , D. E. I. Methods and apparatus for making particles using spray dryer and in-line jet mill . US Patent Application 20050209099, USA . 2005 .
   Google Scholar
• Corrigan , I. 1995 . Thermal analysis of spray dried products . Thermochim. Acta , 248 : 245 – 258 .
   Google Scholar
• Mauludin , R. , Moschwitzer , J. and Muller , R. H. Comparison of different homogenization technologies to produce ultrafine testosterone nanocrystals . Controlled Release Society 34th Annual Meeting . Long Beach, California . CRS .
   Google Scholar
• Moschwitzer , J. and Muller , R. H. 2006 . New method for the effective production of ultrafine drug nanocrystals . J. Nanosci. Nanotechnol. , 6 : 3145 – 3153 .
   Google Scholar
• Liversidge , G. G. , Phillips , C. P. and Cundy , K. C. Method to reduce particle size growth during lyophilization . US Patent 5,302,401 . 1994 . Sterling Winthrop Inc., USA
   Google Scholar
• Gill , P. S. 1984 . Thermal analysis developments in instrumentation and applications . Am. Lab. , 16 : 39 – 49 .
   Google Scholar
• O'Neil , M. J. , ed. 2006 . The Merck Index. An Encyclopedia of Chemicals, Drugs, and Biologicals, , 14th ed. , Whitehouse Station , NJ : Merck & Co. .
   Google Scholar
• Scintag , I. 1999 . Basics of X-ray Diffraction , 7.1 – 7.25 . Cupertino , CA : Scintag . Available online at http://epswww.unm.edu/xrd/xrdbasic.pdf
   Google Scholar
• Buckton , G. and Beezer , A. E. 1992 . The relationship between particle size and solubility . Int. J. Pharm. , 82 : R7 – R10 .
   Google Scholar
• Adamson , A. W. 1976 . Physical Chemistry of Surfaces, , 3rd ed. , 334 – 335 . New York : Wiley .
   Google Scholar
• Muller , R. H. , Jacobs , C. and Kayser , O. 2000 . Nanosuspensions for the Formulation of Poorly Soluble Drugs, Pharmaceutical Emulsions and Suspensions , Edited by: Nielloud , F. and Marti-Mestres , G. 383 – 407 . New York : Marcel Dekker .
   Google Scholar
• Letellier , P. , Mayaffre , A. and Turmine , M. 2007 . Solubility of nanoparticles: non-extensive thermodynamics approach . J. Phys. Condens. Matter , 19 : 1 – 9 .
   Google Scholar
• Wenju , W. and Nancollas , G. H. 1998 . A new understanding of the relationship between solubility and particle size . J. Solut. Chem. , 27 : 521 – 531 .
   Google Scholar
• 2010 . Albendazol http://chemicalland21.com/lifescience/phar/ALBENDAZOLE.htm
   Google Scholar
• Noyes , A. A. and Whitney , W. R. 1987 . The rate of solution of solid substances in their own solutions . J. Am. Chem. Soc. , 19 : 930 – 934 .
   Google Scholar
• Muller , R. H. , Benita , S. and Bohm , B. H. L. 1998 . Emulsions and Nanosuspensions for the Formulation of Poorly Soluble Drugs , Stuttgart : Medpharm Scientific Publishers .
   Google Scholar
• Muller , R. H. and Akkar , A. 2004 . “ Drug nanocrystals of poorly soluble drugs ” . In Encyclopedia of Nanoscience and Nanotechnology , Edited by: Nalwa , H. S. 627 – 638 . California : American Scientific Publishers .
   Google Scholar